TURNER DANIEL K III 4
4 · Orexigen Therapeutics, Inc. · Filed Sep 16, 2009
Insider Transaction Report
Form 4
TURNER DANIEL K III
Director
Transactions
- Sale
Common Stock
2009-09-14$9.00/sh−23,395$210,590→ 1,675,317 total(indirect: By Montreux Equity Partners II, SBIC, LP, Montreux Equity Partners III, SBIC, LP and related funds) - Sale
Common Stock
2009-09-15$8.96/sh−135,701$1,216,315→ 1,539,616 total(indirect: By Montreux Equity Partners II, SBIC, LP Montreux Equity Partners III, SBIC, LP, and related funds) - Sale
Common Stock
2009-09-16$8.93/sh−40,904$365,068→ 1,498,712 total(indirect: By Montreux Equity Partners II, SBIC, LP Montreux Equity Partners III, SBIC, LP, and related funds)
Footnotes (10)
- [F1]11,698 of the 23,395 shares sold, were sold by Montreux Equity Partners II SBIC, L.P. 11,697 of the 23,395 shares sold, were sold by Montreux Equity Partners III SBIC, L.P.
- [F10]Of the total 1,498,712 total shares beneficially owned following the reported transaction, 599,356 shares are held by Montreux Equity Partners II SBIC, L.P. and 899,356 shares are held by Montreux Equity Partners III SBIC, L.P.
- [F2]The sale price reported in this Form 4 was between the range of $9.01 per share and $9.00 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.
- [F3]Of the total 1,673,317 total shares beneficially owned following the reported transaction, 687,658 shares are held by Montreux Equity Partners II SBIC, L.P. and 987,659 shares are held by Montreux Equity Partners III SBIC, L.P.
- [F4]The reported securities are owned directly by Montreux Equity Partners II SBIC, L.P., ("MEP II") and Montreux Equity Partners III SBIC, L.P, ("MEP III"). The voting and disposition of the shares held by MEP II and MEP III are determined by Montreux Equity Management II SBIC, LLC, ("MEM II") and Montreux Equity Management III SBIC, LLC, ("MEM III"), respectively. Mr. Turner is a managing member of MEM II and MEM III. Mr. Turner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F5]67,850 of the 135,701 shares sold, were sold by Montreux Equity Partners II SBIC, L.P. 67,851 of the 135,701 shares sold, were sold by Montreux Equity Partners III SBIC, L.P.
- [F6]The sale price reported in this Form 4 was between the range of $9.00 per share and $8.90 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.
- [F7]Of the total 1,539,616 total shares beneficially owned following the reported transaction, 619,808 shares are held by Montreux Equity Partners II SBIC, L.P. and 919,808 shares are held by Montreux Equity Partners III SBIC, L.P.
- [F8]20,452 of the 40,904 shares sold, were sold by Montreux Equity Partners II SBIC, L.P. 20,452 of the 40,904 shares sold, were sold by Montreux Equity Partners III SBIC, L.P.
- [F9]The sale price reported in this Form 4 was between the range of $8.98 per share and $8.90 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.